Statement from FDA Commissioner Scott Gottlieb, M.D., and Janet Woodcock, M.D., director of the Center for Drug Evaluation and Research on FDA’s ongoing investigation into valsartan impurities and recalls and an update on FDA’s current findings - FDA Press Releases

FDA update on the ongoing investigation into valsartan impurities, recalls and current findings.

from Food and Drug Administration--Press Releases https://ift.tt/2PgYAiH
via IFTTT